GLP-1 RAs, such as tirzepatide and semaglutide, decrease rates of major adverse cardiac events and mortality in patients with diabetes mellitus, but little data exists on their impact in patients with moderate PAD
No adverse effects were reported (PMC9898824)
Freezethaw: Avoid repeated freezethaw cycles
The outcomes discussed or implied in this article may not be typical and should not be considered guarantees of similar results
Sensitivity Indian skin can react to harsh ingredients, strong acids, or environmental stressors
If you are currently on a weight loss medication and considering switching, adding another, or stopping, the most critical advice is always to consult your healthcare provider